| Local myalgia (Without HAattrTMD) | Myofascial pain with referral (Without HAattrTMD) | p | |
---|---|---|---|---|
GCPS version 2.0 | ||||
 Low disability (GCPS 0–2) | 81 (83.5%) | 38 (84.4%) | 0.888 | |
 High disability (GCPS 3–4) | 16 (16.5%) | 7 (15.6%) | ||
Interference score | ||||
 (Mean ± SD) | 22.50 ± 29.03 | 25.33 ± 27.66 | 0.221 | |
 Median (IQR) | 10.00 (0.00–33.33) | 16.66 (3.33–40.00) | ||
PHQ- 9 (Depression) | ||||
 Normal |  ≤ 4 | 61 (61.6%) | 21 (46.7%) | 0.376 |
 Mild | 5–9 | 24 (24.2%) | 16 (35.6%) | |
 Moderate | 10–14 | 7 (7.1%) | 4 (8.9%) | |
 Moderately severe-severe | 15 +  | 7 (7.1%) | 4 (8.9%) | |
PHQ—9 total score | ||||
 (Mean ± SD) | 4.71 ± 5.34 | 6.38 ± 5.61 | 0.033 | |
 Median (IQR) | 3.00 (1.00–7.00) | 6.00 (2.00–8.00) | ||
GAD-7 (Generalized anxiety) | ||||
 Normal |  ≤ 4 | 69 (69.7%) | 26 (57.8%) | 0.501 |
 Mild | 5–9 | 17 (17.2%) | 12 (26.7%) | |
 Moderate | 10–14 | 7 (7.1%) | 4 (8.9%) | |
 Severe | 15 +  | 6 (6.1%) | 3 (6.7%) | |
GAD- 7 total score | ||||
 (Mean ± SD) | 3.85 ± 4.78 | 4.73 ± 5.23 | 0.261 | |
 Median (IQR) | 2.00 (0.00–5.00) | 4.00 (0.00–7.00) | ||
PHQ- 15 (Nonspecific physical symptoms) | ||||
 Normal |  ≤ 4 | 58 (58.6%) | 20 (44.4%) | 0.385 |
 Mild | 5–9 | 28 (28.3%) | 18 (40.0%) | |
 Moderate | 10–14 | 10 (10.1%) | 5 (11.1%) | |
 Severe | 15 +  | 3 (3.0%) | 2 (4.4%) | |
PHQ- 15 total score | ||||
 (Mean ± SD) | 4.34 ± 4.20 | 5.71 ± 4.30 | 0.046 | |
 Median (IQR) | 3.00 (1.00–7.00) | 6.00 (1.50–8.00) |